US Stock MarketDetailed Quotes
CRXT CLARUS THERAPEUTICS HLDGS INC
- 0.000
- 0.0000.00%
15min DelayTrading Nov 22 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)52.02MShares0.07552wk High0.00P/B0Float Cap0.04852wk Low--Dividend TTM37.52MShs Float31.240Historical High--Div YieldTTM0.00%Amplitude0.048Historical Low--Avg Price1Lot Size
CLARUS THERAPEUTICS HLDGS INC Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||||||||
| Cash flow from continuing operating activities | -17.51%-17.5M | -145.21%-17.27M | -5.31%-43.79M | -57.70%-9.33M | -12.52M | -14.89M | -7.04M | -41.58M | -5.92M |
| Net income from continuing operations | 40.97%-10.69M | 3.62%-14.87M | -1,034.80%-40.62M | -1,647.48%-4.3M | ---2.77M | ---18.12M | ---15.43M | --4.35M | --278K |
| Operating gains losses | ---728K | ---642K | 80.86%-12.8M | 62.43%-4.9M | ---- | ---- | ---- | ---66.89M | ---13.04M |
| Depreciation and amortization | 0.00%7K | 40.00%7K | 38.89%25K | 75.00%7K | --6K | --7K | --5K | --18K | --4K |
| Other non cash items | -58.58%2.02M | -181.57%-3.79M | 29.95%16.19M | -58.11%1.93M | --4.75M | --4.88M | --4.64M | --12.46M | --4.6M |
| Change In working capital | -365.56%-8.56M | -55.41%1.59M | -194.57%-7.25M | -232.58%-2.18M | ---6.8M | ---1.84M | --3.57M | --7.66M | --1.64M |
| -Change in receivables | 30.21%-700K | -101.70%-1.66M | 55.89%-1.94M | 162.28%591K | ---704K | ---1M | ---825K | ---4.4M | ---949K |
| -Change in inventory | -8.63%-1.88M | 67.11%-716K | -856.97%-8.36M | -584.64%-1.74M | ---2.72M | ---1.73M | ---2.18M | --1.1M | --358K |
| -Change in prepaid assets | 39.85%186K | 205.45%290K | -251.99%-2.83M | -1,017.14%-782K | ---1.91M | --133K | ---275K | ---804K | ---70K |
| -Change in payables and accrued expense | -990.31%-7.17M | -52.55%3.28M | -48.39%5.47M | -157.66%-1.01M | ---1.25M | --805K | --6.92M | --10.59M | --1.75M |
| -Change in other working capital | 2,225.53%999K | 607.69%396K | -64.76%413K | 37.07%758K | ---220K | ---47K | ---78K | --1.17M | --553K |
| Cash from discontinued investing activities | |||||||||
| Operating cash flow | -17.51%-17.5M | -145.21%-17.27M | -5.31%-43.79M | -57.70%-9.33M | ---12.52M | ---14.89M | ---7.04M | ---41.58M | ---5.92M |
| Investing cash flow | |||||||||
| Cash flow from continuing investing activities | 0 | 9.09%-10K | 60.32%-25K | -400.00%-5K | 0 | -9K | -11K | -63K | -1K |
| Net PPE purchase and sale | --0 | 9.09%-10K | 60.32%-25K | -400.00%-5K | --0 | ---9K | ---11K | ---63K | ---1K |
| Cash from discontinued investing activities | |||||||||
| Investing cash flow | --0 | 9.09%-10K | 60.32%-25K | -400.00%-5K | --0 | ---9K | ---11K | ---63K | ---1K |
| Financing cash flow | |||||||||
| Cash flow from continuing financing activities | 54.56%27.54M | 0 | 33.40%62.99M | 13.8M | 24.19M | 17.82M | 7.18M | 47.22M | 0 |
| Net issuance payments of debt | --0 | --0 | -36.57%32.18M | ---1K | --7.18M | --17.82M | --7.18M | --50.74M | --0 |
| Net common stock issuance | ---- | ---- | --13.8M | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other financing activities | ---- | ---- | 583.76%17.01M | --1K | ---- | ---- | ---- | ---3.52M | --0 |
| Cash from discontinued financing activities | |||||||||
| Financing cash flow | 54.56%27.54M | --0 | 33.40%62.99M | --13.8M | --24.19M | --17.82M | --7.18M | --47.22M | --0 |
| Net cash flow | |||||||||
| Beginning cash position | 24.08%9.14M | 265.20%26.42M | 336.78%7.23M | 66.90%21.95M | --10.28M | --7.36M | --7.23M | --1.66M | --13.15M |
| Current changes in cash | 244.41%10.04M | -13,289.31%-17.28M | 243.95%19.18M | 175.37%4.46M | --11.68M | --2.91M | --131K | --5.58M | ---5.92M |
| End cash Position | 86.54%19.17M | 24.08%9.14M | 265.20%26.42M | 265.20%26.42M | --21.95M | --10.28M | --7.36M | --7.23M | --7.23M |
| Free cash flow | -17.44%-17.5M | -144.97%-17.28M | -5.21%-43.81M | -57.75%-9.34M | ---12.52M | ---14.9M | ---7.05M | ---41.64M | ---5.92M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data